Tin tức & Cập nhật

Clinical considerations for patients at high risk for progression to severe COVID-19

COVID-19 has not gone away. New contagious variants continue to be a leading cause of death, with underlying conditions still influencing the risk of COVID-19 hospitalizations, said Dr Ali Hassoun, Clinical Professor of Medicine and infectious disease specialist at Crestwood Medical Center, Huntsville, Alabama, US, who spoke at a Pfizer-sponsored session during IDWeek 2024.

[Infographic] Thảo luận bàn tròn - Bệnh nhân COPD giai đoạn ổn định: nên điều trị những gì?

[Infographic] Thảo luận bàn tròn - Kết hợp bộ đôi hay bộ ba trong COPD?

Hãy cùng xem qua một số luận điểm của các báo cáo viên về việc có nên thêm ICS khi điều trị COPD và vai trò của việc cá thể hóa điều trị BN COPD khi đưa ra quyết định điều trị

[Infographic] Một số điểm chính về Hội nghị khoa học COPD lần 3 - Phiên toàn thể

Hội nghị với chủ đề “Tầm soát phát hiện sớm và điều trị COPD ở cộng đồng” nhấn mạnh tầm quan trọng và lợi ích của việc tầm soát phát hiện sớm và điều trị COPD ngay tại cộng đồng.

Multipathogen testing an essential part of Test-Target-Treat strategy for respiratory illnesses

At a recent webinar, experts discussed the paradigm shift in respiratory illnesses and treatment practices as the COVID-19 pandemic transitions to an endemic phase. The late Dr Mohan Ravuru, Physician Researcher and former Asia Pacific Medical Director, Abbott, Dr Johnny Sinon, Senior Emergency Physician from Makati Medical Center, Philippines, and Associate Professor Nuntra Suwantarat, Infectious Disease Specialist, from Chulabhorn International College of Medicine, Thammasat University, Thailand, delivered informative presentations and engaged the audience through a stimulating panel discussion.

Among the topics covered were the ‘immunity debt’ phenomenon leading to potential epidemics, challenges in the differential diagnosis of COVID-19 and influenza, and the importance of point-of-care, multipathogen testing as a part of the Test-Target-Treat strategy in respiratory diseases.

Rapid antigen test: Don’t let perfect be the enemy of good

While rapid antigen test is less sensitive than conventional nucleic acid amplification test (NAAT) such as RT-PCR* in detecting SARS-CoV-2 virus, “a test does not have to be perfect to be clinically useful,” said Professor Angela Caliendo during a session in IDWeek 2021 — echoing the maxim that perfect should not be the enemy of good in the pandemic era.

Antigen rapid tests: The new COVID-19 strategy moving forward?

Same-day pre-event screening for SARS-CoV-2 using antigen-detecting rapid diagnostic tests (Ag-RDT) may enable the resumption of large-scale indoor events which were halted or had their attendance capacity reduced during the COVID-19 pandemic, according to a study from Spain presented at ECCMID 2021.

Combined Ag/Ab rapid testing boosts case-finding in COVID-19

A rapid and affordable test for diagnosing COVID-19 outside the walls of the healthcare units could improve case-finding, contact tracing, and infection control, says an expert during a pre-ECCMID 2021 session.